Position in MDXG
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$9,410,285
-$2,518,205 QoQ
Shares Held
2,444,230
-19.1% QoQ
Ownership
1.68%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#11
of 226 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MDXG Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,950,489,724 across 311 Biotechnology names. MDXG ranks #53 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in MDXG
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,410,285 | 2,444,230 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $11,928,490 | 3,019,871 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $16,702,030 | 2,467,065 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $14,017,424 | 2,008,227 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $12,878,517 | 2,107,777 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $14,670,105 | 1,930,277 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $17,359,838 | 1,804,557 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $9,008,199 | 1,524,230 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $10,884,154 | 1,570,585 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $13,525,704 | 1,756,585 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $10,978,154 | 1,251,785 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $7,895,689 | 1,083,085 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $5,951,544 | 900,385 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $2,999,384 | 879,585 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,642,104 | 590,685 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,596,824 | 556,385 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,221,011 | 640,061 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,471,333 | 312,385 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,076,932 | 178,300 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $694,476 | 114,600 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,683,846 | 134,600 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $850,780 | 82,600 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $442,196 | 48,700 | Shares | Sole | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||